GERD Not Responding to Medication: What Comes Next

← Patient Education

GERD not responding to medication is one of the most common reasons adults in Arlington, Annandale, and the rest of Northern Virginia end up in a gastroenterologist's office. The pattern is familiar: a primary care physician suggests a proton pump inhibitor, or you start one from the pharmacy shelf, and for a while it helps. Then the heartburn creeps back, or the regurgitation never really stopped, and months later you are still taking a daily pill and still reaching for antacids. That is the point where the question changes from "how do I treat reflux" to "why is this treatment not working." This guide explains what the American College of Gastroenterology's current guideline says happens next, why reflux medicine sometimes falls short, which tests sort out the cause, and which symptoms mean you should not wait.

This article is general education, not medical advice. Please do not change the dose of a prescribed medication, or stop one, without talking to the physician who prescribed it.

What "GERD not responding to medication" actually means

Gastroesophageal reflux disease, or GERD, is reflux that happens often enough, or causes enough irritation, to be a medical problem rather than an occasional nuisance. Our page on GERD and acid reflux explains the condition itself. This page picks up where that one leaves off: after treatment has started and has not done its job.

The medicines most people are taking at this stage are proton pump inhibitors, usually called PPIs. The National Institute of Diabetes and Digestive and Kidney Diseases describes them as better at treating GERD symptoms than H2 blockers and able to heal the esophageal lining in most people with GERD. That is why a poor response deserves a closer look rather than just a stronger pill.

Gastroenterologists use a specific definition. The 2022 ACG clinical guideline on GERD notes that reflux generally is not considered truly "PPI-refractory" unless a person has been taking a PPI twice a day. It describes the most commonly accepted definition of refractory GERD as persistent heartburn, regurgitation, or both despite 8 weeks of double-dose PPI therapy, and notes that some authorities use 12 weeks. In everyday terms, "my reflux medicine is not working" can mean several different things, and sorting out which one applies to you is the first job of an evaluation.

The usual path: an 8-week trial, then a decision

For adults with classic reflux symptoms, meaning heartburn and regurgitation, and no warning signs, the ACG guideline recommends an 8-week trial of a PPI taken once daily before a meal. What happens after those 8 weeks is where many people's care stalls.

• If symptoms go away, the guideline recommends attempting to stop the PPI. Many people do not need to stay on it indefinitely, and trying to stop is part of the plan, not a failure of it. Our guide to long term PPI use covers safety and how stopping is handled.
• If symptoms do not respond adequately, or return when the PPI is stopped, the guideline recommends a diagnostic upper endoscopy, ideally after the PPI has been stopped for 2 to 4 weeks so the exam is not masked by the medicine.

That second branch is the one people miss. It is common to stay on a partially effective PPI for months or years, adding antacids on bad days, without anyone ever confirming that reflux is the cause. The guideline's answer to a poor response is to find out what is going on, not simply to continue.

Common reasons for GERD not responding to medication

There is no single explanation. In practice, the causes fall into a few groups, and more than one can apply at the same time.

The medicine is not being taken the way it works

PPIs work by switching off the stomach's acid pumps, and those pumps are most active when you eat. The ACG guideline recommends taking a PPI 30 to 60 minutes before a meal rather than at bedtime. For once-daily dosing, that means before the first meal of the day. For twice-daily dosing, it means before breakfast and before dinner. A PPI taken on an empty stomach with no meal to follow, taken at bedtime, or taken only on days when symptoms flare will often underperform. The guideline also points to studies in which simply teaching people the correct timing improved their symptoms and quality of life.

Reflux is still getting through

PPIs reduce acid. They do not stop the stomach's contents from moving back up into the esophagus. When the main problem is regurgitation, the sensation of fluid or food coming back up, a PPI may make that fluid less acidic without making it go away. A hiatal hernia, in which part of the stomach sits above the diaphragm, can weaken the natural barrier against reflux and make symptoms harder to control with medicine alone.

The symptoms are not coming from acid reflux

This is the group that surprises people most. The ACG guideline notes that GERD symptoms are nonspecific and can overlap with, or be confused with, several other conditions, including:

• Eosinophilic esophagitis, an allergic-type inflammation of the esophagus that often causes food to stick. Our page on eosinophilic esophagitis explains how it is diagnosed.
• Achalasia and other motility disorders, in which the esophagus does not move food downward normally.
• Rumination syndrome, an unintentional, learned pattern of bringing recently eaten food back up.
• Reflux hypersensitivity and functional heartburn, in which the esophagus is unusually sensitive, so normal amounts of reflux, or none at all, are felt as burning.
• Delayed stomach emptying, which our page on gastroparesis covers.
• Heart or lung conditions and a paraesophageal hernia, which can produce chest discomfort that feels like heartburn.

Frequent belching can be part of the picture too. A 2025 review in Clinical Gastroenterology and Hepatology recommends considering supragastric belching, a learned pattern of pulling air into the esophagus and pushing it back out, in people whose reflux symptoms do not respond to a PPI. Our page on excessive belching explains how it is recognized and treated.

The guideline also observes that many people diagnosed with GERD on symptoms alone, without testing, likely have functional heartburn, and are therefore unlikely to respond to a PPI no matter how it is dosed. Stomach problems such as gastritis and peptic ulcers can also cause upper abdominal burning that is easy to mistake for reflux. None of these are rare in a gastroenterology practice, and none of them get better with a higher PPI dose.

Everyday factors are working against the medicine

Medicine and daily habits work together. The ACG guideline recommends weight loss for people who are overweight or living with obesity, and cites a study in which women who lowered their body mass index by 3.5 or more saw a 40 percent reduction in frequent GERD symptoms. It also suggests avoiding meals within 2 to 3 hours of bedtime, avoiding tobacco, avoiding the foods that trigger your own symptoms, and raising the head of the bed if symptoms are worse at night. NIDDK describes raising the head 6 to 8 inches with a foam wedge or extra pillows under the head and upper back. These steps rarely fix persistent reflux on their own, but they can make the difference between partial and good control.

Warning signs alongside GERD not responding to medication

An 8-week medication trial is only appropriate when there are no warning signs. The ACG guideline recommends endoscopy as the first test, before or instead of a longer medication trial, for people who have:

• Trouble swallowing, or food that feels stuck. Our page on difficulty swallowing explains why this matters.
• Weight loss you did not intend. See our page on unexplained weight loss.
• Signs of bleeding in the digestive tract, such as vomiting blood or material that looks like coffee grounds, black or tarry stools, or anemia found on blood work.
• Several risk factors for Barrett's esophagus, a change in the esophageal lining linked to long-standing reflux.

If you have any of these alongside reflux that is not responding to medication, schedule an evaluation rather than adjusting the medicine on your own. Chest pain deserves its own caution: pain that feels like heartburn can come from the heart, and the ACG guideline recommends testing for GERD only after heart disease has been adequately evaluated. If you have chest pain with shortness of breath, sweating, or pain spreading to the arm, neck, or jaw, call 911. If your heart has already been evaluated and chest pain continues, our page on noncardiac chest pain explains the digestive workup that comes next.

How a gastroenterologist evaluates GERD not responding to medication

The ACG guideline describes a stepwise approach. Not everyone needs every step, and the order depends on what earlier tests have already shown.

Step one: optimizing the medicine

The guideline's first recommendation for refractory GERD is to optimize PPI therapy. That means confirming the medicine is being taken, and taken at the right time relative to meals. From there, a physician may consider twice-daily dosing, which the guideline notes kept stomach acid better controlled across 24 hours than a single double-strength dose in one analysis, or a switch to a different PPI. The guideline supports one switch for someone who has not responded to a PPI, but says more than one switch cannot be supported. It describes optimization as a simple, low-cost step that helps a small but clinically meaningful number of people.

Step two: an upper endoscopy

An upper endoscopy, also called an EGD, lets a gastroenterologist look directly at the esophagus, stomach, and first part of the small intestine. For persistent symptoms, the ACG guideline recommends doing it after the PPI has been stopped for 2 to 4 weeks, if an off-medication exam has not already been done, and taking biopsies of the esophagus even when the lining looks normal. The biopsies are how conditions like eosinophilic esophagitis are found. The exam can also show inflammation of the esophagus, graded on a scale called the Los Angeles classification, as well as Barrett's esophagus, a narrowing, or a hiatal hernia.

Step three: reflux monitoring

If the endoscopy does not settle the question, the next test measures reflux directly. The ACG guideline describes two main methods. One is a small wireless capsule attached to the lining of the esophagus during an endoscopy, which can record for 48 to 96 hours while you go about normal activities. The other is a thin catheter passed through the nose that usually records for 24 hours and can also detect reflux that is not acidic. Which one is used, and whether you take your PPI during the test, depends on the question being asked:

• Testing off the PPI is recommended when GERD has never been confirmed by an earlier test. The goal is to find out whether you have abnormal reflux at all.
• Testing on the PPI is suggested when GERD is already established and symptoms persist despite twice-daily dosing. The goal is to find out whether reflux is still getting through the medicine, and whether your symptoms line up with the reflux episodes the test records.

Your physician will tell you which applies and how long to hold the medicine beforehand. Please follow those specific instructions rather than a general rule.

Step four: esophageal manometry, when needed

Manometry measures the pressure and muscle movement of the esophagus as you swallow. The ACG guideline recommends considering it when endoscopy and reflux monitoring are both normal, and before any surgical or endoscopic reflux procedure. It is the test that identifies achalasia and other motility problems, and the guideline notes it can also detect rumination and a pattern called supragastric belching, both of which can look like reflux that will not respond to treatment.

Treatment options for GERD not responding to medication, by test result

The value of testing is that it points to a treatment that fits. Broadly, results tend to fall into three groups.

Reflux is confirmed and still getting through. For people with objectively documented reflux whose main persistent symptom is regurgitation, the ACG guideline recommends considering antireflux surgery or a procedure called transoral incisionless fundoplication. Surgical options include laparoscopic fundoplication, which NIDDK describes as the most common surgery for GERD, and magnetic sphincter augmentation, which the guideline recommends considering as an alternative for regurgitation that has not responded to medical management. For people with obesity who are candidates, the guideline also recommends considering gastric bypass as a way to treat GERD. NIDDK notes that complications are more likely with surgery than with medicine, so these are decisions to make carefully with a gastroenterologist and an experienced surgeon, and the guideline stresses that they are only appropriate when reflux has been objectively documented.

Severe inflammation or Barrett's esophagus is found. For the most severe grades of inflammation, Los Angeles grade C or D, the ACG guideline recommends indefinite maintenance PPI therapy or antireflux surgery. Barrett's esophagus comes with its own monitoring plan, which our Barrett's esophagus page explains. In these situations, the PPI is doing important protective work even if it has not fully controlled symptoms, so it should not be stopped without a physician's guidance.

Testing is normal. This is a meaningful answer, not a dead end. When reflux monitoring is normal and symptoms do not track with reflux, the ACG guideline recommends stopping the PPI unless there is another reason to take it. It notes that in one study, 42 percent of people kept taking a PPI after testing had ruled out refractory GERD. A normal result redirects the evaluation toward the conditions listed earlier, such as reflux hypersensitivity, functional heartburn, a motility disorder, or a stomach problem, each of which has its own management.

What usually does not help

When a PPI is not working, it is tempting to keep adding medicines. The ACG guideline recommends against routinely adding other medications for people who have not responded to a PPI. It specifically recommends against baclofen when there is no objective evidence of GERD, against prokinetic medicines of any kind unless there is objective evidence of gastroparesis, and against sucralfate for GERD except during pregnancy. It also notes that a barium swallow should not be used by itself as a test to diagnose GERD. The common thread is that each extra medicine or test should answer a specific question, which is why the evaluation above comes first.

Reflux symptoms outside the esophagus

Some people's reflux shows up as a chronic cough, hoarseness, frequent throat clearing, or a sense of something in the throat, with little or no heartburn. The ACG guideline recommends looking for causes other than GERD before attributing these symptoms to reflux, and recommends reflux testing before starting a PPI when there is no heartburn or regurgitation at all. For people who have both throat or cough symptoms and typical heartburn, it suggests a trial of twice-daily PPI for 8 to 12 weeks, and, if that does not help, an upper endoscopy ideally off the PPI for 2 to 4 weeks, followed by reflux monitoring if the endoscopy is normal. Our page on silent reflux covers how these throat symptoms are evaluated. If this sounds like your situation, it helps to bring notes from any ear, nose, and throat or lung evaluations to your first visit.

Preparing for a visit about GERD not responding to medication

A few details make the first appointment much more productive. Before you come in, try to write down:

• The name and dose of every reflux medicine you have taken, including over-the-counter PPIs, H2 blockers, and antacids, and roughly how long you took each one.
• When and how you take your PPI, including how long before which meal.
• Which symptoms bother you most: burning, regurgitation, cough, trouble swallowing, chest discomfort, or nausea.
• Whether symptoms improved at all on medication, and whether they came back when you stopped.
• Any earlier endoscopy, biopsy, or reflux test results, or the name of the facility where they were done.

Our page on what to expect at your first gastroenterologist visit covers the rest of the appointment.

Care for GERD not responding to medication at GC of NoVA

Gastroenterology Center of Northern Virginia sees patients from Arlington, Annandale, and the surrounding communities whose reflux has not settled with medication. Our five gastroenterologists start with the history, review how medication has been taken and what it has and has not changed, and recommend testing only when it will change the plan. Upper endoscopies are performed at VHC Health, Inova Fairfax Hospital, and the Woodburn Endoscopy Center. When a specialized test or a surgical opinion is needed, we will explain why and coordinate the next step with you.

We see patients at our Arlington office at 1715 N George Mason Drive, adjacent to VHC Health, and our Annandale office at 3299 Woodburn Road in the Woodburn Medical complex. If you have been taking reflux medication for months and still have symptoms, call Arlington at (703) 522-7476 or Annandale at (703) 560-6106, or learn more at gcofnova.com.

This article is for general education and is not medical advice. Talk with a qualified gastroenterologist about your symptoms, diagnosis, and treatment options.